Cedars-Sinai Samuel Oschin Cancer Center — Los Angeles, California

Cedars-Sinai Samuel Oschin Cancer Center is a clinical research site located in Los Angeles, California, United States 90048.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Cedars-Sinai Samuel Oschin Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Kidney Disease, Proteinuria, Children.

Sponsors: Bayer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cedars-Sinai Samuel Oschin Cancer Center?

Cedars-Sinai Samuel Oschin Cancer Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cedars-Sinai Samuel Oschin Cancer Center conducted?

Cedars-Sinai Samuel Oschin Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Kidney Disease, Proteinuria, Children.

Is Cedars-Sinai Samuel Oschin Cancer Center accredited by Crixeo Health?

Cedars-Sinai Samuel Oschin Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cedars-Sinai Samuel Oschin Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.